Jack Kaye
Director/Board Member at DYADIC INTERNATIONAL, INC.
Net worth: 188 259 $ as of 2024-03-30
Profile
Jack L.
Kaye is currently an Independent Director at Dyadic International, Inc., an Independent Non-Executive Director at uniQure NV, and a Director at DiaCarta, Inc. Previously, he served as an Independent Director at Keryx Biopharmaceuticals, Inc. from 2011 to 2016.
He also held director positions at Balboa Biosciences, Inc. and Tongli Pharmaceuticals (USA), Inc. Prior to his director roles, he was a Partner at Deloitte LLP (New York) from 1978 to 2006.
Mr. Kaye received his undergraduate degree from Baruch College.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
UNIQURE N.V.
0.05% | 2023-09-14 | 25,419 ( 0.05% ) | 132 179 $ | 2024-03-30 |
2024-01-02 | 33,581 ( 0.12% ) | 56 080 $ | 2024-03-30 |
Jack Kaye active positions
Companies | Position | Start |
---|---|---|
DYADIC INTERNATIONAL, INC. | Director/Board Member | 2015-04-30 |
UNIQURE N.V. | Director/Board Member | 2016-06-14 |
DiaCarta, Inc.
DiaCarta, Inc. BiotechnologyHealth Technology DiaCarta, Inc. provides novel molecular diagnostics technology and services. Its services include clia lab, NGS target sequencing, next-gen sequencing, companion diagnostics and cart-T immunotheraphy. The company was founded by Paul Okunieff and Aiguo Zhang in 2010 and is headquartered in Richmond, CA. | Director/Board Member | 2022-04-06 |
Former positions of Jack Kaye
Companies | Position | End |
---|---|---|
KERYX BIOPHARMACEUTICALS | Director/Board Member | 2016-05-24 |
TONGLI PHARMACEUTICALS (USA), INC. | Director/Board Member | 2009-06-18 |
Deloitte LLP (New York)
Deloitte LLP (New York) Miscellaneous Commercial ServicesCommercial Services Deloitte LLP (New York) engages in the provision of audit, consulting, tax, and advisory solutions. It offers services relating to tax, consulting, audit and assurance, Deloitte private company services, mergers and acquisitions, risk and financial advisory, analytics, and cloud. The company was founded by William Welch Deloitte, George A. Touche, Charles Waldo Haskins, and Elijah Watt Sells in 1845 and is headquartered in New York, NY. | Corporate Officer/Principal | 2006-04-30 |
Balboa Biosciences, Inc.
Balboa Biosciences, Inc. BiotechnologyHealth Technology Balboa Biosciences, Inc. operates as a biopharmaceutical company. It develops therapeutics for central nervous system disorders. The company is headquartered in San Diego, CA. | Director/Board Member | - |
Training of Jack Kaye
Baruch College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
DYADIC INTERNATIONAL, INC. | Health Services |
UNIQURE N.V. | Health Technology |
Private companies | 5 |
---|---|
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
Deloitte LLP (New York)
Deloitte LLP (New York) Miscellaneous Commercial ServicesCommercial Services Deloitte LLP (New York) engages in the provision of audit, consulting, tax, and advisory solutions. It offers services relating to tax, consulting, audit and assurance, Deloitte private company services, mergers and acquisitions, risk and financial advisory, analytics, and cloud. The company was founded by William Welch Deloitte, George A. Touche, Charles Waldo Haskins, and Elijah Watt Sells in 1845 and is headquartered in New York, NY. | Commercial Services |
Balboa Biosciences, Inc.
Balboa Biosciences, Inc. BiotechnologyHealth Technology Balboa Biosciences, Inc. operates as a biopharmaceutical company. It develops therapeutics for central nervous system disorders. The company is headquartered in San Diego, CA. | Health Technology |
Tongli Pharmaceuticals (USA), Inc.
Tongli Pharmaceuticals (USA), Inc. Pharmaceuticals: MajorHealth Technology Tongli Pharmaceuticals (USA), Inc. engages in the production, development, and distribution of pharmaceutical healthcare products. The company was founded by Ming Li Yao on November 26, 1999 and is headquartered in Flushing, NY. | Health Technology |
DiaCarta, Inc.
DiaCarta, Inc. BiotechnologyHealth Technology DiaCarta, Inc. provides novel molecular diagnostics technology and services. Its services include clia lab, NGS target sequencing, next-gen sequencing, companion diagnostics and cart-T immunotheraphy. The company was founded by Paul Okunieff and Aiguo Zhang in 2010 and is headquartered in Richmond, CA. | Health Technology |
- Stock Market
- Insiders
- Jack Kaye